The prevalence and antimicrobial susceptibility of circulating S. pneumoniae serotypes in adult population in Russia (epidemiological study «SPECTRUM»)

R. Kozlov, A. Muravyev, A. Chagaryan, N. Ivanchik, A. Kurkova, A. Kuzmenkov, I. V. Trushin, M. Sukhorukova
{"title":"The prevalence and antimicrobial susceptibility of circulating S. pneumoniae serotypes in adult population in Russia (epidemiological study «SPECTRUM»)","authors":"R. Kozlov, A. Muravyev, A. Chagaryan, N. Ivanchik, A. Kurkova, A. Kuzmenkov, I. V. Trushin, M. Sukhorukova","doi":"10.36488/cmac.2021.2.127-137","DOIUrl":null,"url":null,"abstract":"Objective. To estimate prevalence and antimicrobial susceptibility of circulated S. pneumoniae serotypes in adult population in different regions of the Russian Federation. Materials and Methods. A total of 500 isolates of S. pneumoniae obtained from patients with invasive pneumococcal disease (IPD), community-acquired pneumonia (CAP), sinusitis/acute otitis media (AOM) and healthy carriers from 29 centers were included in the study from 01 June 2019 to 15 January 2020. Re-identification, typing using real-time PCR with 27 primer pairs and antimicrobial susceptibility testing were performed in the central laboratory by standardized methods. Results. Among 50 isolates from patients with IPD, the following serotypes were detected: 3 (20.0%), 23F (10.0%), 6ABCD (8.0%), 19F (6.0%), 12ABF, 4, 7AF, 8, 9NL, 9VA, 15B (4.0% each), 1, 10A, 11AD, 14, 15AF, 18ABCF, 22AF, 33F/33A/37 (2.0% each). PCV-13 and PPV-23 covered 62.0% and 86.0% of those serotypes, respectively. Among 357 isolates from patients with CAP, the following serotypes were detected: 19F (12.3%), 6ABCD (11.5%), 3 (10.1%), 23F (5.9%), 14 (5.3%), 22AF (5.0%), 11AD (4.8%), 9NL (3.4%), 15AF (2.8%), 9VA (2.2%), 18ABCF (2.0%), 19A (1.7%), 12ABF (1.4%), 17F (0.8%), 16, 33F/33A/37, 7AF and 8 (0.6% each), 10A and 4 (0,3% each); serotypes were not specified due to the PCR typing protocol limitations for 106 (29.8%) isolates. PCV-13 and PPV-23 covered 51.9% and 68.7% of those serotypes, respectively. In patients with sinusitis/AOM (n = 48), serotypes were: 19F (18.8%), 6ABCD (16.7%), 23F (12.5%), 3 (12.5%), 18ABCF (6.3%), 11AD (4.2%), 14 (4.2%), 22AF (4.2%), 15AF, 4, 9VA (2.1% each). PCV-13 and PPV-23 covered 75.0% and 83.3% of those serotypes, respectively. In healthy nasopharyngeal carriers (n = 45), the following serotypes were detected: 19F (24.4%), 3 (17.8%), 6ABCD (17.8%), 11AD (13.3%), 23F (8.9%), 22AF (6.7%), 14 and 15AF (2.2% each). PCV-13 and PPV-23 covered 71.1% and 91.1% of those serotypes, respectively. Serotypes 14, 19F, and 19A were frequently resistant to three antibiotics – penicillin, erythromycin, and tetracycline. Resistance to respiratory quinolones was very low (0.7%) and detected among serotypes 14 and 9NL only. The majority of non-vaccine serotypes did not have substantial antimicrobial resistance problems. Conclusions. Despite the relatively low number of isolates in all but CAP group and limitations of PCR typing protocol, results of our study support the use of pneumococcal vaccines (PPV-23 and PCV-13) in Russian adult population, with some advantages of PPV-23 over PCV-13.","PeriodicalId":53392,"journal":{"name":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36488/cmac.2021.2.127-137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

Abstract

Objective. To estimate prevalence and antimicrobial susceptibility of circulated S. pneumoniae serotypes in adult population in different regions of the Russian Federation. Materials and Methods. A total of 500 isolates of S. pneumoniae obtained from patients with invasive pneumococcal disease (IPD), community-acquired pneumonia (CAP), sinusitis/acute otitis media (AOM) and healthy carriers from 29 centers were included in the study from 01 June 2019 to 15 January 2020. Re-identification, typing using real-time PCR with 27 primer pairs and antimicrobial susceptibility testing were performed in the central laboratory by standardized methods. Results. Among 50 isolates from patients with IPD, the following serotypes were detected: 3 (20.0%), 23F (10.0%), 6ABCD (8.0%), 19F (6.0%), 12ABF, 4, 7AF, 8, 9NL, 9VA, 15B (4.0% each), 1, 10A, 11AD, 14, 15AF, 18ABCF, 22AF, 33F/33A/37 (2.0% each). PCV-13 and PPV-23 covered 62.0% and 86.0% of those serotypes, respectively. Among 357 isolates from patients with CAP, the following serotypes were detected: 19F (12.3%), 6ABCD (11.5%), 3 (10.1%), 23F (5.9%), 14 (5.3%), 22AF (5.0%), 11AD (4.8%), 9NL (3.4%), 15AF (2.8%), 9VA (2.2%), 18ABCF (2.0%), 19A (1.7%), 12ABF (1.4%), 17F (0.8%), 16, 33F/33A/37, 7AF and 8 (0.6% each), 10A and 4 (0,3% each); serotypes were not specified due to the PCR typing protocol limitations for 106 (29.8%) isolates. PCV-13 and PPV-23 covered 51.9% and 68.7% of those serotypes, respectively. In patients with sinusitis/AOM (n = 48), serotypes were: 19F (18.8%), 6ABCD (16.7%), 23F (12.5%), 3 (12.5%), 18ABCF (6.3%), 11AD (4.2%), 14 (4.2%), 22AF (4.2%), 15AF, 4, 9VA (2.1% each). PCV-13 and PPV-23 covered 75.0% and 83.3% of those serotypes, respectively. In healthy nasopharyngeal carriers (n = 45), the following serotypes were detected: 19F (24.4%), 3 (17.8%), 6ABCD (17.8%), 11AD (13.3%), 23F (8.9%), 22AF (6.7%), 14 and 15AF (2.2% each). PCV-13 and PPV-23 covered 71.1% and 91.1% of those serotypes, respectively. Serotypes 14, 19F, and 19A were frequently resistant to three antibiotics – penicillin, erythromycin, and tetracycline. Resistance to respiratory quinolones was very low (0.7%) and detected among serotypes 14 and 9NL only. The majority of non-vaccine serotypes did not have substantial antimicrobial resistance problems. Conclusions. Despite the relatively low number of isolates in all but CAP group and limitations of PCR typing protocol, results of our study support the use of pneumococcal vaccines (PPV-23 and PCV-13) in Russian adult population, with some advantages of PPV-23 over PCV-13.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
俄罗斯成年人群中流行肺炎链球菌血清型的流行率和抗菌药物敏感性(流行病学研究«SPECTRUM»)
目标。目的评估俄罗斯联邦不同地区成年人群中流行肺炎链球菌血清型的流行率和抗菌药物敏感性。材料与方法。2019年6月1日至2020年1月15日,研究人员将来自29个中心的侵袭性肺炎球菌病(IPD)、社区获得性肺炎(CAP)、鼻窦炎/急性中耳炎(AOM)患者和健康携带者的500株肺炎链球菌纳入研究。结果50株IPD患者分离株中检出血清型分别为3(20.0%)、23F(10.0%)、6ABCD(8.0%)、19F(6.0%)、12ABF、4、7AF、8、9NL、9VA、15B(各4.0%)、1、10A、11AD、14、15AF、18ABCF、22AF、33F/33A/37(各2.0%)。PCV-13和PPV-23的血清型覆盖率分别为62.0%和86.0%。在357株CAP患者分离株中检出以下血清型:19F(12.3%)、6ABCD(11.5%)、3(10.1%)、23F(5.9%)、14(5.3%)、22AF(5.0%)、11AD(4.8%)、9NL(3.4%)、15AF(2.8%)、9VA(2.2%)、18ABCF(2.0%)、19A(1.7%)、12ABF(1.4%)、17F(0.8%)、16、33F/33A/37、7AF和8(各0.6%)、10A和4(各0.3%);106株(29.8%)分离株由于PCR分型方案的限制,未明确血清型。PCV-13和PPV-23的血清型覆盖率分别为51.9%和68.7%。鼻窦炎/AOM患者(48例)血清型分别为:19F(18.8%)、6ABCD(16.7%)、23F(12.5%)、3(12.5%)、18ABCF(6.3%)、11AD(4.2%)、14(4.2%)、22AF(4.2%)、15AF、4、9VA(各占2.1%)。PCV-13和PPV-23分别覆盖75.0%和83.3%的血清型。在健康鼻咽带菌者(n = 45)中,检出血清型分别为19F(24.4%)、3(17.8%)、6ABCD(17.8%)、11AD(13.3%)、23F(8.9%)、22AF(6.7%)、14和15AF(各2.2%)。PCV-13和PPV-23分别覆盖了71.1%和91.1%的血清型。血清型14、19F和19A常对青霉素、红霉素和四环素三种抗生素耐药。呼吸道喹诺酮类药物耐药率很低(0.7%),仅在14和9NL血清型中检测到。结论:尽管除CAP组外所有血清型的分离株数量相对较少,且PCR分型方案存在局限性,但我们的研究结果支持在俄罗斯成年人群中使用肺炎球菌疫苗(PPV-23和PCV-13), PPV-23比PCV-13具有一定的优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
审稿时长
8 weeks
期刊最新文献
Current approaches and prospects for the development of laboratory diagnosis of measles The known-unknown: third- and fourth-generation cephalosporins combined with sulbactam Prospects for the use of statins in antiviral therapy AMRexpert – online platform for interpretation, verification and validation of antimicrobial susceptibility testing Anti-staphylococcal activity and cytocompatibility of lysostaphin
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1